438 related articles for article (PubMed ID: 21406405)
41. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
42. MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells.
Shi Y; Frost P; Hoang B; Yang Y; Fukunaga R; Gera J; Lichtenstein A
Oncogene; 2013 Jan; 32(2):190-7. PubMed ID: 22370634
[TBL] [Abstract][Full Text] [Related]
43. Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo.
Nogueira L; Ruiz-Ontañon P; Vazquez-Barquero A; Lafarga M; Berciano MT; Aldaz B; Grande L; Casafont I; Segura V; Robles EF; Suarez D; Garcia LF; Martinez-Climent JA; Fernandez-Luna JL
Oncogene; 2011 Aug; 30(32):3537-48. PubMed ID: 21423202
[TBL] [Abstract][Full Text] [Related]
44. Translational control of human neutrophil responses by MNK1.
Fortin CF; Mayer TZ; Cloutier A; McDonald PP
J Leukoc Biol; 2013 Oct; 94(4):693-703. PubMed ID: 23401599
[TBL] [Abstract][Full Text] [Related]
45. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy.
Grzmil M; Seebacher J; Hess D; Behe M; Schibli R; Moncayo G; Frank S; Hemmings BA
Cell Signal; 2016 Sep; 28(9):1412-1421. PubMed ID: 27289018
[TBL] [Abstract][Full Text] [Related]
47. Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
Hui IC; Tung EK; Sze KM; Ching YP; Ng IO
Liver Int; 2010 Jan; 30(1):65-75. PubMed ID: 19845851
[TBL] [Abstract][Full Text] [Related]
48. N-Hydroxycinnamide derivatives of osthole inhibit cell migration and invasion by suppressing Smad2 and Akt pathways in human colorectal adenocarcinoma cells.
Liu LY; Huang WJ; Ho FM; Lin RJ; Lin SY; Suk FM; Liang YC
Chem Biol Interact; 2014 Jun; 217():1-8. PubMed ID: 24727557
[TBL] [Abstract][Full Text] [Related]
49. Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
Bell JB; Eckerdt F; Dhruv HD; Finlay D; Peng S; Kim S; Kroczynska B; Beauchamp EM; Alley K; Clymer J; Goldman S; Cheng SY; James CD; Nakano I; Horbinski C; Mazar AP; Vuori K; Kumthekar P; Raizer J; Berens ME; Platanias LC
Mol Cancer Res; 2018 Jan; 16(1):32-46. PubMed ID: 29042487
[TBL] [Abstract][Full Text] [Related]
50. Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.
Dreas A; Mikulski M; Milik M; Fabritius CH; Brzózka K; Rzymski T
Curr Med Chem; 2017; 24(28):3025-3053. PubMed ID: 28164761
[TBL] [Abstract][Full Text] [Related]
51. CDK2 phosphorylation of Smad2 disrupts TGF-beta transcriptional regulation in resistant primary bone marrow myeloma cells.
Baughn LB; Di Liberto M; Niesvizky R; Cho HJ; Jayabalan D; Lane J; Liu F; Chen-Kiang S
J Immunol; 2009 Feb; 182(4):1810-7. PubMed ID: 19201832
[TBL] [Abstract][Full Text] [Related]
52. [Expression of the proteins associated with transforming growth factor-beta/Smad signaling pathway in Peutz-Jeghers syndrome].
Wang YJ; Li LJ; Wu BP; Jiang B
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):774-6. PubMed ID: 20423848
[TBL] [Abstract][Full Text] [Related]
53. Pharmacologic co-inhibition of Mnks and mTORC1 synergistically suppresses proliferation and perturbs cell cycle progression in blast crisis-chronic myeloid leukemia cells.
Teo T; Yu M; Yang Y; Gillam T; Lam F; Sykes MJ; Wang S
Cancer Lett; 2015 Feb; 357(2):612-23. PubMed ID: 25527453
[TBL] [Abstract][Full Text] [Related]
54. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
[TBL] [Abstract][Full Text] [Related]
55. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
Boström AK; Lindgren D; Johansson ME; Axelson H
Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
[TBL] [Abstract][Full Text] [Related]
56. Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling.
Li S; Liu X; Chen X; Zhang L; Wang X
Tumour Biol; 2015 Dec; 36(12):9661-5. PubMed ID: 26150340
[TBL] [Abstract][Full Text] [Related]
57. MNK1 kinase activity is required for abscission.
Rannou Y; Salaun P; Benaud C; Khan J; Dutertre S; Giet R; Prigent C
J Cell Sci; 2012 Jun; 125(Pt 12):2844-52. PubMed ID: 22454512
[TBL] [Abstract][Full Text] [Related]
58. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of eIF4E by MNKs supports protein synthesis, cell cycle progression and proliferation in prostate cancer cells.
Bianchini A; Loiarro M; Bielli P; Busà R; Paronetto MP; Loreni F; Geremia R; Sette C
Carcinogenesis; 2008 Dec; 29(12):2279-88. PubMed ID: 18809972
[TBL] [Abstract][Full Text] [Related]
60. Rapamycin enhances eIF4E phosphorylation by activating MAP kinase-interacting kinase 2a (Mnk2a).
Stead RL; Proud CG
FEBS Lett; 2013 Aug; 587(16):2623-8. PubMed ID: 23831578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
